Cytokine release syndrome: Difference between revisions

From IDWiki
(Created page with "== Background == * Adverse effect of CAR-T and BiTE therapies == Clinical Manifestations == * Fever, hypotension, tachypnea, tachycardia, headache, rash, dyspnea, hypoxemia == ASTCT CRS GradingCiteRef::lee2019as == {| class="wikitable" !Parameter !Grade 1 !Grade 1 !Grade 3 !Grade 4 |- |Fever |≥38ºC |≥38ºC |≥38ºC |≥38ºC |- | colspan="5" |with |- |Hypotension |— |Not on vasopressors |One vasopressor ± vasopressin |Multiple vasopressors |- | c...")
 
mNo edit summary
Line 39: Line 39:
 
[[Category:Hematology]]
 
[[Category:Hematology]]
 
[[Category:Oncology]]
 
[[Category:Oncology]]
  +
[[Category:Adverse drug reactions]]

Revision as of 21:46, 25 March 2024

Background

Clinical Manifestations

  • Fever, hypotension, tachypnea, tachycardia, headache, rash, dyspnea, hypoxemia

ASTCT CRS Grading1

Parameter Grade 1 Grade 1 Grade 3 Grade 4
Fever ≥38ºC ≥38ºC ≥38ºC ≥38ºC
with
Hypotension Not on vasopressors One vasopressor ± vasopressin Multiple vasopressors
and/or
Hypoxia Low-flow nasal cannula High-flow nasal cannula, facemask, nonrebreather mask, Venturi mask Positive-pressure ventilation (non-invasive or invasive)

References

  1. ^  Daniel W. Lee, Bianca D. Santomasso, Frederick L. Locke, Armin Ghobadi, Cameron J. Turtle, Jennifer N. Brudno, Marcela V. Maus, Jae H. Park, Elena Mead, Steven Pavletic, William Y. Go, Lamis Eldjerou, Rebecca A. Gardner, Noelle Frey, Kevin J. Curran, Karl Peggs, Marcelo Pasquini, John F. DiPersio, Marcel R.M. van den Brink, Krishna V. Komanduri, Stephan A. Grupp, Sattva S. Neelapu. ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells. Biology of Blood and Marrow Transplantation. 2019;25(4):625-638. doi:10.1016/j.bbmt.2018.12.758.